Low efficacy and high frequency of adverse event in a randomized trial of the triple nucleoside regimen abacavir, stavudine and didanosine.

J Gerstoft; O Kirk; N Obel; C Pedersen; Lars Reinhardt Mathiesen; H Nielsen; TL Katzenstein; Jens Dilling Lundgren

Low efficacy and high frequency of adverse event in a randomized trial of the triple nucleoside regimen abacavir, stavudine and didanosine.

J Gerstoft, O Kirk, N Obel, C Pedersen, Lars Reinhardt Mathiesen, H Nielsen, TL Katzenstein, Jens Dilling Lundgren

72 Citations (Scopus)

Original language	English
Journal	AIDS
ISSN	0269-9370
Publication status	Published - 2003

Access to Document

http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=14502007

Cite this

Gerstoft, J., Kirk, O., Obel, N., Pedersen, C., Mathiesen, L. R., Nielsen, H., Katzenstein, TL., & Lundgren, J. D. (2003). Low efficacy and high frequency of adverse event in a randomized trial of the triple nucleoside regimen abacavir, stavudine and didanosine. AIDS. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=14502007

@article{54b46293c19f4389938f26c3e34bba24,

title = "Low efficacy and high frequency of adverse event in a randomized trial of the triple nucleoside regimen abacavir, stavudine and didanosine.",

author = "J Gerstoft and O Kirk and N Obel and C Pedersen and Mathiesen, {Lars Reinhardt} and H Nielsen and TL Katzenstein and Lundgren, {Jens Dilling}",

year = "2003",

language = "English",

journal = "AIDS, Supplement",

issn = "1350-2840",

publisher = "Lippincott Williams & Wilkins",

}

TY - JOUR

T1 - Low efficacy and high frequency of adverse event in a randomized trial of the triple nucleoside regimen abacavir, stavudine and didanosine.

AU - Gerstoft, J

AU - Kirk, O

AU - Obel, N

AU - Pedersen, C

AU - Mathiesen, Lars Reinhardt

AU - Nielsen, H

AU - Katzenstein, TL

AU - Lundgren, Jens Dilling

PY - 2003

Y1 - 2003

M3 - Journal article

SN - 1350-2840

JO - AIDS, Supplement

JF - AIDS, Supplement

ER -